LLY
Eli Lilly and Company
Score
73/100
⭐⭐⭐⭐⭐
4.8/5
·
55 yrs
Safety
70
Sust.
82
Yield
60
Growth
77
Yield
0.8%
Payout
25%
Yrs paying
55+
Price
Yield
Payment
LLY
Eli Lilly and Company
Overall Score
73/100
In middle 50% of industry · Better than 25% of industry
Reliability
⭐⭐⭐⭐⭐
4.8/5.0
55 yrs
i
Safety
70
i
Sustainability
82
i
Yield
60
i
Growth
77
Near industry median
Current Yield
0.77% · Below avg
Payout Ratio
25.2%
Consecutive Years
54+
Price
Yield
Payment
Company Profile
Company Name
Eli Lilly and Company
NYSE
Classification
Healthcare
Drug Manufacturers General
Market Cap
$871.60B
Beta
0.50
P/E Ratio
52.79
Industry P/E
49.21
Company Description
Eli Lilly and Company discovers develops and markets human pharmaceuticals worldwide It offers Basaglar Humalog Humalog Mix 7525 Humalog U100 Humalog U200 Humalog Mix 5050 insulin lispro insulin lispro protamine insulin lispro mix 7525 Humulin Humulin 7030 Humulin N Humulin R and Humulin U500 for diabetes and Jardiance Trajenta and Trulicity for type 2 diabetes The company provides Alimta for nonsmall cell lung cancer NSCLC and malignant pleural mesothelioma Cyramza for metastatic gastric cancer gastroesophageal junction adenocarcinoma metastatic NSCLC metastatic colorectal cancer and hepatocellular carcinoma Erbitux for colorectal cancers and various head and neck cancers Retevmo for metastatic NSCLC medullary thyroid cancer and thyroid cancer Tyvyt for relapsed or refractory classic Hodgkins lymph and nonsquamous NSCLC and Verzenio for HR HER2 metastatic breast cancer node positive and early breast cancer It offers Olumiant for rheumatoid arthritis and Taltz for plaque psoriasis psoriatic arthritis ankylosing spondylitis and nonradiographic axial spondylarthritis The company offers Cymbalta for depressive disorder diabetic peripheral neuropathic pain generalized anxiety disorder fibromyalgia and chronic musculoskeletal pain Emgality for migraine prevention and episodic cluster headache and Zyprexa for schizophrenia bipolar I disorder and bipolar maintenance Its Bamlanivimab and etesevimab and Bebtelovimab for COVID19 Cialis for erectile dysfunction and benign prostatic hyperplasia and Forteo for osteoporosis The company has collaborations with Incyte Corporation Boehringer Ingelheim Pharmaceuticals Inc AbCellera Biologics Inc Junshi Biosciences Regor Therapeutics Group Lycia Therapeutics Inc Kumquat Biosciences Inc Entos Pharmaceuticals Inc and Foghorn Therapeutics Inc Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis Indiana
Numbers shown in millions | Currency: USD
| Metrics | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue & Profitability | |||||
| Total Revenue | 65.18B | 45.04B | 34.12B | 28.54B | 28.32B |
| Cost of Revenue | 10.56B | 8.42B | 7.08B | 6.63B | 7.31B |
| Gross Profit | 54.62B | 36.62B | 27.04B | 21.91B | 21.01B |
| Gross Margin % | 83.79% | 81.31% | 79.25% | 76.77% | 74.18% |
| Operating Expenses | |||||
| R&D Expenses | 13.34B | 10.99B | 9.31B | 7.19B | 7.03B |
| SG&A Expenses | 11.09B | 8.59B | 6.94B | 6.44B | 6.43B |
| Other Operating Expenses | 487.50M | N/A | N/A | -52.10M | 0.00 |
| Total Operating Expenses | 24.92B | 19.58B | 16.25B | 13.63B | 13.46B |
| Operating Performance | |||||
| Operating Income | 29.70B | 12.90B | 10.33B | 7.13B | 6.36B |
| Operating Margin % | 45.56% | 28.64% | 30.26% | 24.97% | 22.45% |
| EBITDA | 27.94B | 15.23B | 8.57B | 9.43B | 8.04B |
| EBITDA Margin % | 42.86% | 33.81% | 25.11% | 33.05% | 28.40% |
| Net Results | |||||
| Interest Expense | 795.30M | 780.60M | 485.90M | 331.60M | 339.80M |
| Other Income/Expenses Net | -3.97B | -218.60M | -3.77B | -320.90M | -201.60M |
| Income Before Tax | 25.73B | 12.68B | 6.55B | 6.81B | 6.16B |
| Income Tax Expense | 5.09B | 2.09B | 1.31B | 561.60M | 573.80M |
| Net Income | 20.64B | 10.59B | 5.24B | 6.24B | 5.58B |
| Net Margin % | 31.66% | 23.51% | 15.36% | 21.88% | 19.71% |
| Per Share Metrics | |||||
| EPS | 23.00 | 11.76 | 5.83 | 6.93 | 6.15 |
| Diluted EPS | 22.95 | 11.71 | 5.80 | 6.90 | 6.12 |
Numbers shown in millions | Currency: USD
| Metrics | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | 7.16B | 3.27B | 2.82B | 2.07B | 3.82B |
| Short Term Investments | 105.00M | 154.80M | 109.10M | 144.80M | 90.10M |
| Net Receivables | 20.16B | 13.28B | 11.34B | 8.56B | 8.13B |
| Inventory | 13.74B | 7.59B | 5.77B | 4.31B | 3.89B |
| Other Current Assets | 14.46B | 8.45B | 5.69B | 2.95B | 2.53B |
| Total Current Assets | 55.63B | 32.74B | 25.73B | 18.03B | 18.45B |
| Non-Current Assets | |||||
| Property, Plant & Equipment (Net) | 24.68B | 17.10B | 12.91B | 10.14B | 8.99B |
| Long Term Investments | 2.80B | 3.22B | 3.05B | 2.90B | 3.21B |
| Tax Assets | 9.96B | 8.00B | 5.48B | 2.79B | 2.49B |
| Other Non-Current Assets | 6.99B | 5.72B | 4.99B | 4.34B | 4.08B |
| Total Non-Current Assets | 56.85B | 45.98B | 38.28B | 31.46B | 30.35B |
| Total Assets | |||||
| Total Assets | 112.48B | 78.71B | 64.01B | 49.49B | 48.81B |
| Current Liabilities | |||||
| Accounts Payable | 5.38B | 3.23B | 2.60B | 1.93B | 1.67B |
| Short Term Debt | 1.64B | 5.12B | 6.90B | 1.50B | 1.54B |
| Tax Payables | 5.88B | N/A | 3.85B | 475.10M | 126.90M |
| Deferred Revenue | N/A | N/A | 14.51B | N/A | N/A |
| Other Current Liabilities | 22.34B | 20.03B | 13.94B | 13.71B | 11.72B |
| Total Current Liabilities | 35.23B | 28.38B | 27.29B | 17.14B | 15.05B |
| Non-Current Liabilities | |||||
| Long Term Debt | 40.87B | 28.53B | 18.32B | 14.74B | 15.35B |
| Other Non-Current Liabilities | 9.85B | 7.54B | 7.53B | 6.75B | 7.52B |
| Total Non-Current Liabilities | 50.71B | 36.07B | 25.85B | 21.58B | 24.60B |
| Total Liabilities | |||||
| Total Liabilities | 85.94B | 64.44B | 53.14B | 38.71B | 39.65B |
| Shareholders Equity | |||||
| Common Stock | 590.00M | 592.40M | 593.60M | 594.10M | 596.30M |
| Retained Earnings | 24.47B | 13.55B | 10.31B | 10.04B | 8.96B |
| Accumulated Other Comprehensive Income/Loss | -2.88B | -4.32B | -4.33B | -3.84B | -4.34B |
| Total Shareholders Equity | 26.54B | 14.19B | 10.77B | 10.65B | 8.98B |
| Key Metrics | |||||
| Total Liabilities & Equity | 112.48B | 78.71B | 64.01B | 49.49B | 48.63B |
| Total Debt | 42.50B | 33.64B | 25.23B | 16.24B | 16.88B |
| Net Debt | 35.34B | 30.38B | 22.41B | 14.17B | 13.07B |
Numbers shown in millions | Currency: USD
| Metrics | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 20.64B | 10.59B | 5.24B | 6.24B | 5.58B |
| Depreciation & Amortization | 2.00B | 1.77B | 1.53B | 1.52B | 1.55B |
| Stock Based Compensation | 626.00M | 645.60M | 628.50M | 371.10M | 342.80M |
| Change in Accounts Receivable | -7.00B | -2.16B | -2.45B | -299.60M | N/A |
| Change in Inventory | -4.67B | -2.51B | -1.43B | -599.70M | -235.90M |
| Change in Accounts Payable | 10.19B | 2.61B | 4.27B | 1.33B | -664.10M |
| Other Working Capital Changes | -6.61B | -3.33B | -3.45B | -446.90M | 3.40B |
| Total Working Capital Change | -8.09B | -5.39B | -3.06B | -14.50M | -1.02B |
| Other Non-Cash Items | 3.35B | 3.88B | 2.24B | 1.15B | 1.61B |
| Net Cash from Operations | 16.81B | 8.82B | 4.24B | 7.08B | 7.26B |
| Investing Activities | |||||
| Capital Expenditures | -7.84B | -5.06B | -7.39B | -2.48B | -1.31B |
| Purchase of Investments | -645.00M | -775.80M | -829.00M | -707.60M | -1.01B |
| Sale of Investments | 964.00M | 522.50M | 700.30M | 463.60M | 847.40M |
| Other Investing Activities | -2.79B | -3.04B | 1.41B | -206.40M | -539.10M |
| Net Cash from Investing | -10.97B | -9.30B | -7.15B | -3.26B | -2.76B |
| Financing Activities | |||||
| Debt Repayment | 8.05B | 8.90B | -8.65B | -1.56B | -1.91B |
| Stock Repurchases | -4.11B | -2.50B | -750.00M | -1.50B | -1.25B |
| Dividends Paid | -5.38B | -4.68B | -4.07B | -3.54B | -3.09B |
| Other Financing Activities | -772.00M | -490.60M | -335.00M | 1.19B | 2.11B |
| Net Cash from Financing | -2.21B | 1.23B | 3.50B | -5.41B | -4.13B |
| Cash Summary | |||||
| Net Change in Cash | 4.00B | 449.80M | 751.60M | -1.75B | 161.40M |
| Cash at Beginning of Period | 3.27B | 2.82B | 2.07B | 3.82B | 3.66B |
| Cash at End of Period | 7.27B | 3.27B | 2.82B | 2.07B | 3.82B |
| Operating Cash Flow | 16.81B | 8.82B | 4.24B | 7.08B | 7.26B |
| Capital Expenditure | -7.84B | -8.40B | -7.39B | -2.48B | -1.87B |
| Free Cash Flow | 8.97B | 414.30M | -3.15B | 4.60B | 5.39B |
Consecutive Years
55
Years with dividends
Consecutive Increases
37
47/53 total increases
Payment Frequency
Quarterly
4.20 payments/year
📊 Annual Dividend History (Split-Adjusted)
Note: The latest year (2026) is incomplete with
1/4 payments.
Annual Dividend Summary
| Year | Annual Total | Yield | Payments | YoY Change | YoY % | CAGR 5Y | CAGR 10Y |
|---|---|---|---|---|---|---|---|
| 2026 P | $1.7300 | 0.17% | 1 | N/A | N/A | N/A | N/A |
| 2025 | $6.0000 | 0.74% | 4 | +$0.8000 | +15.38% | 15.18% | 11.61% |
| 2024 | $5.2000 | 0.65% | 4 | $-0.4500 | -7.96% | 15.05% | 10.25% |
| 2023 | $5.6500 | 1.17% | 5 | +$1.7300 | +44.13% | 20.22% | 11.17% |
| 2022 | $3.9200 | 1.35% | 4 | +$0.5200 | +15.29% | 13.51% | 7.18% |
| 2021 | $3.4000 | 1.51% | 4 | +$0.4400 | +14.86% | 10.76% | 5.66% |
| 2020 | $2.9600 | 2.01% | 4 | +$0.3800 | +14.73% | 8.16% | 4.21% |
| 2019 | $2.5800 | 2.25% | 4 | +$0.3300 | +14.67% | 5.65% | 2.79% |
| 2018 | $2.2500 | 2.48% | 4 | +$0.1700 | +8.17% | 2.80% | 1.81% |
| 2017 | $2.0800 | 2.59% | 4 | +$0.0400 | +1.96% | 1.20% | 2.04% |
| 2016 | $2.0400 | 2.65% | 4 | +$0.0400 | +2.00% | 0.80% | 2.46% |
| 2015 | $2.0000 | 2.62% | 4 | +$0.0400 | +2.04% | 0.40% | 2.78% |
| 2014 | $1.9600 | 3.27% | 4 | +$0.0000 | 0.00% | 0.00% | 3.28% |
| 2013 | $1.9600 | 3.66% | 4 | +$0.0000 | 0.00% | 0.84% | 3.88% |
| 2012 | $1.9600 | 4.63% | 4 | +$0.0000 | 0.00% | 2.89% | 4.68% |
| 2011 | $1.9600 | 5.40% | 4 | +$0.0000 | 0.00% | 4.14% | 5.76% |
| 2010 | $1.9600 | 5.58% | 4 | +$0.0000 | 0.00% | 5.22% | 6.54% |
| 2009 | $1.9600 | 5.61% | 4 | +$0.0800 | +4.26% | 6.66% | 7.86% |
| 2008 | $1.8800 | 4.36% | 4 | +$0.1800 | +10.59% | 7.01% | 8.92% |
| 2007 | $1.7000 | 3.06% | 4 | +$0.1000 | +6.25% | 6.51% | 8.67% |
| 2006 | $1.6000 | 2.98% | 4 | +$0.0800 | +5.26% | 7.39% | 8.85% |
| 2005 | $1.5200 | 2.78% | 4 | +$0.1000 | +7.04% | 7.89% | 8.78% |
| 2004 | $1.4200 | 2.16% | 4 | +$0.0800 | +5.97% | 9.07% | 8.55% |
| 2003 | $1.3400 | 2.14% | 4 | +$0.1000 | +8.06% | 10.87% | 8.28% |
| 2002 | $1.2400 | 1.96% | 4 | +$0.1200 | +10.71% | 10.88% | 8.47% |
| 2001 | $1.1200 | 1.40% | 4 | +$0.0800 | +7.69% | 10.33% | 8.40% |
| 2000 | $1.0400 | 1.41% | 4 | +$0.1200 | +13.04% | 9.69% | 9.76% |
📅 Quarterly Payments by Year
2026
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2026 | $1.7300 | 0.166% | $1,040.00 |
2025
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 14, 2025 | $1.5000 | 0.178% | $844.27 |
| May 16, 2025 | $1.5000 | 0.198% | $757.39 |
| Aug 15, 2025 | $1.5000 | 0.214% | $701.23 |
| Nov 14, 2025 | $1.5000 | 0.146% | $1,025.28 |
2024
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 14, 2024 | $1.3000 | 0.172% | $757.31 |
| May 15, 2024 | $1.3000 | 0.165% | $787.02 |
| Aug 15, 2024 | $1.3000 | 0.140% | $931.58 |
| Nov 15, 2024 | $1.3000 | 0.174% | $746.20 |
2023
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 14, 2023 | $1.1300 | 0.325% | $347.56 |
| May 12, 2023 | $1.1300 | 0.260% | $434.43 |
| Aug 14, 2023 | $1.1300 | 0.210% | $538.00 |
| Sep 8, 2023 | $1.1300 | 0.193% | $586.46 |
| Nov 14, 2023 | $1.1300 | 0.185% | $610.82 |
2022
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 14, 2022 | $0.9800 | 0.418% | $234.69 |
| May 13, 2022 | $0.9800 | 0.336% | $291.63 |
| Aug 12, 2022 | $0.9800 | 0.318% | $308.08 |
| Nov 14, 2022 | $0.9800 | 0.275% | $356.06 |
2021
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 11, 2021 | $0.8500 | 0.420% | $202.58 |
| May 13, 2021 | $0.8500 | 0.436% | $194.94 |
| Aug 12, 2021 | $0.8500 | 0.323% | $263.47 |
| Nov 12, 2021 | $0.8500 | 0.327% | $259.65 |
2020
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2020 | $0.7400 | 0.522% | $141.80 |
| May 14, 2020 | $0.7400 | 0.467% | $158.38 |
| Aug 13, 2020 | $0.7400 | 0.492% | $150.46 |
| Nov 12, 2020 | $0.7400 | 0.525% | $141.03 |
2019
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 14, 2019 | $0.6450 | 0.534% | $120.75 |
| May 16, 2019 | $0.6450 | 0.553% | $116.73 |
| Aug 14, 2019 | $0.6450 | 0.585% | $110.29 |
| Nov 14, 2019 | $0.6450 | 0.579% | $111.39 |
2018
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 14, 2018 | $0.5630 | 0.730% | $77.03 |
| May 16, 2018 | $0.5630 | 0.693% | $81.18 |
| Aug 14, 2018 | $0.5630 | 0.549% | $102.44 |
| Nov 14, 2018 | $0.5630 | 0.512% | $109.81 |
2017
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2017 | $0.5200 | 0.669% | $77.77 |
| May 11, 2017 | $0.5200 | 0.648% | $80.22 |
| Aug 11, 2017 | $0.5200 | 0.641% | $81.15 |
| Nov 14, 2017 | $0.5200 | 0.630% | $82.49 |
2016
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 10, 2016 | $0.5100 | 0.698% | $73.07 |
| May 11, 2016 | $0.5100 | 0.668% | $76.31 |
| Aug 11, 2016 | $0.5100 | 0.633% | $80.56 |
| Nov 10, 2016 | $0.5100 | 0.651% | $78.34 |
2015
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 11, 2015 | $0.5000 | 0.715% | $69.95 |
| May 14, 2015 | $0.5000 | 0.684% | $73.06 |
| Aug 12, 2015 | $0.5000 | 0.600% | $83.38 |
| Nov 10, 2015 | $0.5000 | 0.625% | $80.06 |
2014
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 12, 2014 | $0.4900 | 0.919% | $53.32 |
| May 13, 2014 | $0.4900 | 0.816% | $60.04 |
| Aug 13, 2014 | $0.4900 | 0.809% | $60.59 |
| Nov 12, 2014 | $0.4900 | 0.727% | $67.40 |
2013
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2013 | $0.4900 | 0.917% | $53.44 |
| May 14, 2013 | $0.4900 | 0.877% | $55.87 |
| Aug 13, 2013 | $0.4900 | 0.892% | $54.96 |
| Nov 13, 2013 | $0.4900 | 0.969% | $50.55 |
2012
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2012 | $0.4900 | 1.261% | $38.85 |
| May 11, 2012 | $0.4900 | 1.188% | $41.26 |
| Aug 13, 2012 | $0.4900 | 1.145% | $42.81 |
| Nov 13, 2012 | $0.4900 | 1.039% | $47.14 |
2011
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 11, 2011 | $0.4900 | 1.419% | $34.52 |
| May 11, 2011 | $0.4900 | 1.280% | $38.28 |
| Aug 11, 2011 | $0.4900 | 1.388% | $35.30 |
| Nov 10, 2011 | $0.4900 | 1.316% | $37.23 |
2010
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 10, 2010 | $0.4900 | 1.434% | $34.17 |
| May 12, 2010 | $0.4900 | 1.409% | $34.78 |
| Aug 11, 2010 | $0.4900 | 1.335% | $36.71 |
| Nov 10, 2010 | $0.4900 | 1.400% | $34.99 |
2009
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 11, 2009 | $0.4900 | 1.334% | $36.72 |
| May 13, 2009 | $0.4900 | 1.394% | $35.15 |
| Aug 12, 2009 | $0.4900 | 1.488% | $32.94 |
| Nov 10, 2009 | $0.4900 | 1.390% | $35.25 |
2008
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2008 | $0.4700 | 0.934% | $50.34 |
| May 13, 2008 | $0.4700 | 0.988% | $47.55 |
| Aug 13, 2008 | $0.4700 | 0.971% | $48.38 |
| Nov 12, 2008 | $0.4700 | 1.469% | $31.99 |
2007
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2007 | $0.4250 | 0.783% | $54.28 |
| May 11, 2007 | $0.4250 | 0.727% | $58.43 |
| Aug 13, 2007 | $0.4250 | 0.747% | $56.93 |
| Nov 13, 2007 | $0.4250 | 0.807% | $52.64 |
2006
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2006 | $0.4000 | 0.723% | $55.35 |
| May 11, 2006 | $0.4000 | 0.782% | $51.12 |
| Aug 11, 2006 | $0.4000 | 0.736% | $54.36 |
| Nov 13, 2006 | $0.4000 | 0.740% | $54.06 |
2005
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 11, 2005 | $0.3800 | 0.685% | $55.50 |
| May 11, 2005 | $0.3800 | 0.647% | $58.75 |
| Aug 11, 2005 | $0.3800 | 0.708% | $53.64 |
| Nov 10, 2005 | $0.3800 | 0.739% | $51.40 |
2004
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 11, 2004 | $0.3550 | 0.475% | $74.70 |
| May 12, 2004 | $0.3550 | 0.482% | $73.71 |
| Aug 11, 2004 | $0.3550 | 0.567% | $62.60 |
| Nov 10, 2004 | $0.3550 | 0.638% | $55.62 |
2003
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 12, 2003 | $0.3350 | 0.569% | $58.89 |
| May 13, 2003 | $0.3350 | 0.525% | $63.80 |
| Aug 13, 2003 | $0.3350 | 0.539% | $62.20 |
| Nov 12, 2003 | $0.3350 | 0.506% | $66.19 |
2002
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2002 | $0.3100 | 0.407% | $76.12 |
| May 13, 2002 | $0.3100 | 0.480% | $64.58 |
| Aug 13, 2002 | $0.3100 | 0.554% | $56.00 |
| Nov 13, 2002 | $0.3100 | 0.514% | $60.29 |
2001
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 13, 2001 | $0.2800 | 0.350% | $79.99 |
| May 11, 2001 | $0.2800 | 0.334% | $83.90 |
| Aug 13, 2001 | $0.2800 | 0.357% | $78.46 |
| Nov 13, 2001 | $0.2800 | 0.355% | $78.97 |
2000
| Date | Amount (Adj) | Yield | Price on Date |
|---|---|---|---|
| Feb 11, 2000 | $0.2600 | 0.422% | $61.63 |
| May 11, 2000 | $0.2600 | 0.347% | $74.88 |
| Aug 11, 2000 | $0.2600 | 0.338% | $77.00 |
| Nov 13, 2000 | $0.2600 | 0.302% | $86.13 |
Overall Dividend Score
73
B- - Good
Composite assessment of dividend quality across safety, sustainability, yield, and growth.
Score Components
Safety
70
Good
Payout ratios, balance sheet strength, and financial stability.
Sustainability
82
Sustainable
Earnings coverage, cash flow, and business resilience.
Yield
60
Fair Yield
Current yield vs. market averages and historical trends.
Growth
77
Strong Growth
Dividend growth history and future potential.